Public-registry site landscape for NCT03381625, a Psoriasis study sponsored by BioMimetix JV, LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03381625 (registry record) |
| Sponsor | BioMimetix JV, LLC |
| Condition(s) | Psoriasis; Atopic Dermatitis |
| Phase | PHASE2 |
| Listed sites | 10 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT03381625 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →